Scott Norris is a Neurology physician. ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4921 Parkview Pl
Div Neurology Movement Disorders, 7th Fl
Saint Louis, MO 631101032
Telephone
314-362-6908Registry record last updated 17 Apr 2025.
Clinical trials
- Neuroimaging of Parkinson's
Sponsor: Washington University School of Medicine
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Turing Medical TechnologiesProgram year20231 payment
- Smith+Nephew, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
96.7%Neuromuscular Blocker96.6%Onabotulinumtoxina100%Part B, office-administered≥52 patientsgamma-Aminobutyric Acid-ergic Agonist0.1%Baclofen100%Part D<11 patients+ 1 more class in this area
Nervous system
2.9%Aromatic Amino Acid Decarboxylation Inhibitor1.1%Carbidopa-Levodopa79%Carbidopa-Levodopa Er16%Carbidopa3%Rytary2%Part D<11 patientsBenzodiazepine0.3%Clonazepam92%Lorazepam8%Part D<11 patients+ 14 more classes in this area
Cardiovascular
0.3%Beta blocker0.2%Propranolol Hcl66%Propranolol Hcl Er34%Part D<11 patientsalpha-Adrenergic Agonist0.1%Midodrine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2022–2026 per NIH RePORTER. The latest:
- Precision mapping of Parkinson's Disease pathophysiology in the Somato-Cognitive Action Network’s DBS targets
Washington University
FY2026$615,690R01NS140256 - The Role of Striatal Cholinergic Interneurons in Dystonia
Washington University
FY2026$611,310R01NS124789 - Precision mapping of Parkinson's Disease pathophysiology in the Somato-Cognitive Action Network’s DBS targets
Washington University
FY2025$613,897R01NS140256
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”